It was the summer of 2002 when the news about hormone replacement therapy
(HRT) shook us to the core.
In what felt like a bomb dropped on all womankind, the U.S. federal
government halted the hormone trial of the Women's Health Initiative early – a
study designed to evaluate the risks and benefits of hormone replacement
therapy on disease prevention.
The reason: Not only had HRT failed to be the protective fountain of youth
doctors and women had long since believed, evidence was mounting...